RAC3 and hepatocellular carcinoma: Our findings align with emerging evidence suggesting RAC3 acts as a context-dependent oncogene in specific HCC molecular subgroups (e.g., SOX6-high), while its function may be compensated or inactivated in others (including subtypes represented by HuH-7 or the analyzed TCGA cohort) [31].